<DOC>
	<DOCNO>NCT01579955</DOCNO>
	<brief_summary>This study conduct Japan . The aim non-interventional study investigate safety effectiveness treatment eptacog alpha ( NovoSeven速 ) normal clinical practice condition .</brief_summary>
	<brief_title>Non-Interventional Study NovoSeven速 Used Patients With Haemophilia A B With Inhibitors Under Normal Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patients haemophilia A B inhibitor receive eptacog alpha ( NovoSeven速 ) treatment Patients deem appropriate treatment eptacog alpha ( NovoSeven速 )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>